HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrea Tannapfel Selected Research

Circulating Tumor DNA

1/2024Dynamic changes in tumor profiling reveal intra- and inter-tumoral heterogeneity focused on an uncharacterized HER2 mutation: a case report of a young breast cancer patient.
1/2022The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217).
1/2021Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal Cancer.
12/2020Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial.
1/2017Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrea Tannapfel Research Topics

Disease

100Neoplasms (Cancer)
03/2024 - 01/2002
22Adenocarcinoma
01/2023 - 01/2004
19Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 07/2005
16Carcinoma (Carcinomatosis)
10/2019 - 08/2002
11Neoplasm Metastasis (Metastasis)
05/2023 - 10/2004
9Pancreatic Neoplasms (Pancreatic Cancer)
03/2024 - 05/2006
9Mesothelioma
01/2018 - 09/2009
9Ischemia
11/2007 - 06/2002
8Lung Neoplasms (Lung Cancer)
05/2021 - 07/2005
8Adenoma (Adenomas)
01/2020 - 11/2002
8Fibrosis (Cirrhosis)
06/2018 - 04/2002
8Hepatocellular Carcinoma (Hepatoma)
01/2012 - 01/2002
7Breast Neoplasms (Breast Cancer)
01/2024 - 11/2005
7Pancreatitis
10/2022 - 07/2003
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 05/2002
7Inflammation (Inflammations)
02/2019 - 04/2003
6Colonic Neoplasms (Colon Cancer)
12/2022 - 01/2012
6Type 2 Diabetes Mellitus (MODY)
01/2022 - 02/2009
6Melanoma (Melanoma, Malignant)
12/2017 - 12/2003
6Squamous Cell Carcinoma of Head and Neck
11/2009 - 05/2002
5Occupational Diseases (Occupational Disease)
05/2021 - 01/2011
5Chronic Pancreatitis
01/2020 - 01/2004
5Sarcoma (Soft Tissue Sarcoma)
01/2014 - 12/2003
5Cholangiocarcinoma
02/2010 - 08/2002
5Carcinogenesis
01/2008 - 08/2002
4Prostatic Neoplasms (Prostate Cancer)
11/2021 - 04/2010
4Urinary Bladder Neoplasms (Bladder Cancer)
05/2021 - 01/2018
4Ovarian Neoplasms (Ovarian Cancer)
05/2021 - 03/2011
4Microsatellite Instability
01/2021 - 08/2003
4Wounds and Injuries (Trauma)
09/2019 - 01/2004
4Colitis
07/2019 - 11/2006
4Malignant Mesothelioma
09/2012 - 10/2009
4Hepatitis C
08/2008 - 08/2005
4Reperfusion Injury
01/2004 - 06/2002
3Stomach Neoplasms (Stomach Cancer)
11/2023 - 05/2017
3Margins of Excision
01/2023 - 06/2003
3Pancreatic Fistula (Pancreatic Fistulas)
02/2022 - 05/2015
3Ulcerative Colitis
07/2020 - 03/2012
3Pulmonary Edema
01/2017 - 04/2003
3Pathologic Constriction (Stenosis)
11/2015 - 01/2009
3Klatskin Tumor
11/2015 - 06/2003
3Disease Progression
10/2015 - 09/2006
3Lymphatic Metastasis
11/2010 - 05/2006
3Neuroendocrine Tumors (Neuroendocrine Tumor)
08/2006 - 08/2004
3Infections
08/2006 - 02/2002
3Aneuploidy (Aneuploid)
07/2006 - 05/2003

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
10/2023 - 02/2002
23Biomarkers (Surrogate Marker)IBA
07/2020 - 01/2002
21DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2002
12AsbestosIBA
05/2021 - 10/2009
11Messenger RNA (mRNA)IBA
01/2018 - 01/2002
10Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 - 10/2004
9MicroRNAs (MicroRNA)IBA
12/2018 - 10/2008
7Fluorouracil (Carac)FDA LinkGeneric
01/2021 - 03/2011
7Tumor Suppressor Protein p14ARF (p14ARF)IBA
08/2004 - 02/2002
6Bevacizumab (Avastin)FDA Link
12/2018 - 01/2008
6Protein Isoforms (Isoforms)IBA
06/2018 - 11/2002
6ParaffinIBA
01/2018 - 01/2004
6EnzymesIBA
08/2004 - 08/2002
5Circulating Tumor DNAIBA
01/2024 - 01/2017
5Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019 - 01/2004
5Formaldehyde (Formol)FDA Link
01/2018 - 01/2004
5Endothelin A ReceptorIBA
03/2007 - 03/2003
5Cyclin-Dependent Kinase Inhibitor p16IBA
08/2004 - 02/2002
4Peptides (Polypeptides)IBA
01/2021 - 11/2005
4Leucovorin (Folinic Acid)FDA Link
01/2021 - 10/2015
4Small Interfering RNA (siRNA)IBA
09/2019 - 10/2006
4Phosphotransferases (Kinase)IBA
11/2018 - 12/2003
4Capecitabine (Xeloda)FDA Link
12/2016 - 03/2011
4Antiviral Agents (Antivirals)IBA
08/2015 - 09/2006
4CarcinogensIBA
01/2012 - 01/2002
4RNA (Ribonucleic Acid)IBA
10/2008 - 08/2005
4Ribavirin (Virazole)FDA LinkGeneric
08/2008 - 08/2005
3Cetuximab (Erbitux)FDA Link
11/2023 - 07/2012
3SteroidsIBA
01/2023 - 08/2006
3ErbB Receptors (EGF Receptor)IBA
01/2021 - 08/2006
3AntibodiesIBA
01/2021 - 02/2002
3AntigensIBA
12/2020 - 07/2003
3Insulin (Novolin)FDA Link
01/2020 - 02/2009
3Tumor Biomarkers (Tumor Markers)IBA
12/2018 - 07/2003
3ORALIT (ORS)IBA
11/2018 - 01/2018
3CytokinesIBA
11/2018 - 08/2003
3Cisplatin (Platino)FDA LinkGeneric
12/2016 - 09/2007
3Glucose (Dextrose)FDA LinkGeneric
11/2016 - 02/2009
3Anti-Bacterial Agents (Antibiotics)IBA
10/2013 - 06/2008
3Glutamic Acid (Glutamate)FDA Link
09/2012 - 12/2003
3Codon (Codons)IBA
08/2012 - 05/2006
3Cyclin D1IBA
03/2012 - 04/2006
3Interferon-alpha2bIBA
12/2007 - 08/2005

Therapy/Procedure

44Therapeutics
01/2024 - 01/2002
20Drug Therapy (Chemotherapy)
11/2023 - 01/2002
8Liver Transplantation
05/2023 - 10/2004
6Neoadjuvant Therapy
05/2022 - 01/2008
5Pancreaticoduodenectomy
01/2023 - 06/2003
4Radiotherapy
03/2024 - 01/2018
4Pancreatectomy
10/2022 - 04/2008
4Photochemotherapy (Photodynamic Therapy)
11/2015 - 06/2003
4Lasers (Laser)
11/2015 - 10/2003
3Immunotherapy
03/2019 - 04/2010
3Pancreas Transplantation
02/2009 - 06/2002